Prasad Again at CBER After 10-Day California ‘Trip’
He’s again! Not two weeks after information broke that Vinay Prasad would depart as chief of the FDA’s Heart for...
Pharmaceutical Updates
Podcast: ePRO defined – Pharmaceutical Expertise
Credit score: GlobalData. Episode three of The Zelta Podcast collection seems on the present state of play for ePRO within...
D.C. Analysis: Trump’s method to well being care, Sarepta’s lobbyists
You’re studying the net version of D.C. Analysis, STAT’s twice-weekly e-newsletter in regards to the politics and coverage of well...
Novartis Continues Hunt for New Belongings With Rumored Takeover of RNA Specialist Avidity
Novartis has approached uncommon disease-focused Avidity Biosciences with an acquisition provide, The Monetary Occasions reported on Wednesday, citing nameless sources...
Teva’s Ajovy turns into first migraine prevention drug authorised for kids
One in ten youngsters and adolescents within the US endure from migraines, one of the frequent neurological situations. Credit score:...
STAT+: Meta violated CA privateness act over Flo interval app knowledge
You’re studying the online version of STAT’s Well being Tech publication, our information to how know-how is reworking the life...
Pfizer CEO in Contact With President Over Most Favored Nation Drug Pricing
Pfizer CEO Albert Bourla has been in direct contact with President Donald Trump and his healthcare chiefs to barter a...
Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition
Sandoz will take management of Simply – Evotec Biologics’ biosimilar manufacturing facility in Toulouse, France. Picture credit score: EXTREME PHOTOGRAPHER...
STAT+: Up and down the ladder: The most recent comings and goings
Employed somebody new and thrilling? Promoted a rising star? Lastly solved that hard-to-fill spot? Share the information with us, and...
Moderna Wins UK Patent Battle In opposition to Pfizer and BioNTech
The U.Okay. Courtroom of Appeals has dominated in Moderna’s favor in a patent dispute between the vaccine maker and its...
Moderna sharpens concentrate on $1.5bn price chopping plan after 41% income stoop
Moderna has reported Q2 income losses of 41%, primarily pushed by drop in COVID vaccine gross sales. Picture credit score:...
AIDS activists sue HHS to get Gilead settlement over PrEP patents
A affected person advocacy group is suing the Trump administration for failing to reveal particulars of a latest settlement with...
Regulatory Roadblocks Blemish Regeneron’s In any other case Sturdy Q2
Regeneron delivered a second-quarter efficiency that handily beat analyst expectations, however regulatory snags tempered enthusiasm over the corporate’s outcomes.On Friday,...
George Tidmarsh to sub in as FDA CBER head following Prasad’s shock exit
The FDA has appointed George Tidmarsh because the short-term director of CBER after Vinay Prasad’s sudden exit. Picture credit score:...
George Tidmarsh named performing head of FDA’s CBER
George Tidmarsh, the Meals and Drug Administration’s prime drug regulator, will tackle further obligations on a short lived foundation after...
